• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种折叠体-树状聚合物缀合物中和了具有神经毒性的β-淀粉样寡聚物。

A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.

机构信息

Department of Medical Chemistry, University of Szeged, Szeged, Hungary.

出版信息

PLoS One. 2012;7(7):e39485. doi: 10.1371/journal.pone.0039485. Epub 2012 Jul 30.

DOI:10.1371/journal.pone.0039485
PMID:22859942
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3408453/
Abstract

BACKGROUND AND AIMS

Unnatural self-organizing biomimetic polymers (foldamers) emerged as promising materials for biomolecule recognition and inhibition. Our goal was to construct multivalent foldamer-dendrimer conjugates which wrap the synaptotoxic β-amyloid (Aβ) oligomers with high affinity through their helical foldamer tentacles. Oligomeric Aβ species play pivotal role in Alzheimer's disease, therefore recognition and direct inhibition of this undruggable target is a great current challenge.

METHODS AND RESULTS

Short helical β-peptide foldamers with designed secondary structures and side chain chemistry patterns were applied as potential recognition segments and their binding to the target was tested with NMR methods (saturation transfer difference and transferred-nuclear Overhauser effect). Helices exhibiting binding in the µM region were coupled to a tetravalent G0-PAMAM dendrimer. In vitro biophysical (isothermal titration calorimetry, dynamic light scattering, transmission electron microscopy and size-exclusion chromatography) and biochemical tests (ELISA and dot blot) indicated the tight binding between the foldamer conjugates and the Aβ oligomers. Moreover, a selective low nM interaction with the low molecular weight fraction of the Aβ oligomers was found. Ex vivo electrophysiological experiments revealed that the new material rescues the long-term potentiation from the toxic Aβ oligomers in mouse hippocampal slices at submicromolar concentration.

CONCLUSIONS

The combination of the foldamer methodology, the fragment-based approach and the multivalent design offers a pathway to unnatural protein mimetics that are capable of specific molecular recognition, and has already resulted in an inhibitor for an extremely difficult target.

摘要

背景和目的

非天然自组织仿生聚合物(foldamers)作为生物分子识别和抑制的有前途的材料而出现。我们的目标是构建多价 foldamer-树状聚合物缀合物,通过其螺旋 foldamer 触手高亲和力地包裹毒性突触的β-淀粉样蛋白(Aβ)寡聚物。寡聚 Aβ 物种在阿尔茨海默病中起关键作用,因此识别和直接抑制这个难以成药的靶标是当前的巨大挑战。

方法和结果

具有设计的二级结构和侧链化学模式的短螺旋β-肽 foldamers 被用作潜在的识别片段,并通过 NMR 方法(饱和转移差异和转移核 Overhauser 效应)测试它们与靶标的结合。在 µM 区域表现出结合的螺旋体与四价 G0-PAMAM 树状聚合物偶联。体外生物物理(等温滴定量热法、动态光散射、透射电子显微镜和尺寸排阻色谱)和生化测试(ELISA 和点印迹)表明 foldamer 缀合物与 Aβ 寡聚物之间的紧密结合。此外,还发现与 Aβ 寡聚物的低分子量部分具有选择性的低 nM 相互作用。离体电生理实验表明,该新材料以亚微摩尔浓度在小鼠海马切片中从毒性 Aβ 寡聚物中挽救长时程增强。

结论

foldamer 方法、基于片段的方法和多价设计的结合为具有特定分子识别能力的非天然蛋白质模拟物提供了一条途径,并且已经产生了针对极其困难的靶标的抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/88d33cd2d87b/pone.0039485.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/89606a944516/pone.0039485.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/6aa73bde2c5c/pone.0039485.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/1164447d0a38/pone.0039485.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/fe5838595e00/pone.0039485.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/85b9c261e19e/pone.0039485.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/c574d352f5a5/pone.0039485.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/8d6221ba020d/pone.0039485.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/cf9e380bcddd/pone.0039485.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/5dfb6fac2e91/pone.0039485.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/6c4d047175ce/pone.0039485.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/953d08e5b72a/pone.0039485.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/88d33cd2d87b/pone.0039485.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/89606a944516/pone.0039485.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/6aa73bde2c5c/pone.0039485.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/1164447d0a38/pone.0039485.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/fe5838595e00/pone.0039485.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/85b9c261e19e/pone.0039485.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/c574d352f5a5/pone.0039485.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/8d6221ba020d/pone.0039485.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/cf9e380bcddd/pone.0039485.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/5dfb6fac2e91/pone.0039485.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/6c4d047175ce/pone.0039485.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/953d08e5b72a/pone.0039485.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b78/3408453/88d33cd2d87b/pone.0039485.g012.jpg

相似文献

1
A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.一种折叠体-树状聚合物缀合物中和了具有神经毒性的β-淀粉样寡聚物。
PLoS One. 2012;7(7):e39485. doi: 10.1371/journal.pone.0039485. Epub 2012 Jul 30.
2
Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers.折叠体-树状聚合物缀合物作为多价剂对抗淀粉样β寡聚物的毒性作用的结构优化。
Molecules. 2018 Oct 2;23(10):2523. doi: 10.3390/molecules23102523.
3
Multivalent foldamer-based affinity assay for selective recognition of Aβ oligomers.基于多价折叠体的亲和分析用于Aβ寡聚体的选择性识别
Anal Chim Acta. 2017 Apr 1;960:131-137. doi: 10.1016/j.aca.2017.01.013. Epub 2017 Jan 24.
4
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.NR2B 含 NMDA 受体和 mGluR5 代谢型谷氨酸受体在介导 β-淀粉样寡聚体对小鼠海马切片长时程增强(LTP)的突触毒性作用中的治疗意义。
Neuropharmacology. 2011 May;60(6):982-90. doi: 10.1016/j.neuropharm.2011.01.051. Epub 2011 Feb 12.
5
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.来自阿尔茨海默病大脑的淀粉样β蛋白的大可溶性寡聚体的神经活性远低于它们解离形成的较小寡聚体。
J Neurosci. 2017 Jan 4;37(1):152-163. doi: 10.1523/JNEUROSCI.1698-16.2016.
6
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.锌离子迅速诱导阿尔茨海默病中具有毒性的、非淀粉样蛋白途径的淀粉样-β寡聚体,而不是淀粉样-β衍生的可扩散配体。
Sci Rep. 2018 Mar 19;8(1):4772. doi: 10.1038/s41598-018-23122-x.
7
Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.固态 MAS NMR 光谱揭示淀粉样β寡聚物与人朊病毒蛋白复合物的结构细节。
J Biol Chem. 2021 Jan-Jun;296:100499. doi: 10.1016/j.jbc.2021.100499. Epub 2021 Mar 3.
8
MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.MRZ-99030 - 一种新型的β-淀粉样蛋白聚集调节剂:II - 逆转β-淀粉样蛋白寡聚体诱导的大鼠和小鼠长期增强(LTP)及认知能力缺陷
Neuropharmacology. 2015 May;92:170-82. doi: 10.1016/j.neuropharm.2014.12.037. Epub 2015 Jan 28.
9
Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.可溶性朊蛋白及其N端片段可预防Aβ寡聚体对突触可塑性的损害:对阿尔茨海默病新型治疗策略的启示。
Neurobiol Dis. 2016 Jul;91:124-131. doi: 10.1016/j.nbd.2016.03.001. Epub 2016 Mar 3.
10
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.淀粉样β蛋白的天然分泌寡聚体在体内可有效抑制海马体长期增强效应。
Nature. 2002 Apr 4;416(6880):535-9. doi: 10.1038/416535a.

引用本文的文献

1
Scalable Synthesis of All Stereoisomers of 2-Aminocyclopentanecarboxylic Acid─A Toolbox for Peptide Foldamer Chemistry.可扩展合成 2-氨基环戊烷羧酸的所有立体异构体——肽折叠物化学的工具包。
J Org Chem. 2024 Apr 5;89(7):4760-4767. doi: 10.1021/acs.joc.3c02991. Epub 2024 Mar 27.
2
siRNA drug delivery across the blood-brain barrier in Alzheimer's disease.siRNA 药物递送至阿尔茨海默病的血脑屏障。
Adv Drug Deliv Rev. 2023 Aug;199:114968. doi: 10.1016/j.addr.2023.114968. Epub 2023 Jun 21.
3
Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation.

本文引用的文献

1
Synthesis and Biological Evaluation of a Cyclo-β-tetrapeptide as a Somatostatin Analogue.一种环β-四肽作为生长抑素类似物的合成及生物学评价
Angew Chem Int Ed Engl. 1999 May 3;38(9):1223-1226. doi: 10.1002/(SICI)1521-3773(19990503)38:9<1223::AID-ANIE1223>3.0.CO;2-A.
2
Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.β-淀粉样蛋白聚集肽调节剂的构效关系:α,α-二取代的变化导致聚集物的大小和形态发生改变。
ACS Chem Neurosci. 2010 Sep 15;1(9):608-26. doi: 10.1021/cn100045q. Epub 2010 Jul 8.
3
利用配体导向片段连接鉴定β-链介导的蛋白质-蛋白质相互作用抑制剂
Chem Sci. 2021 Jan 6;12(6):2286-2293. doi: 10.1039/d0sc05694d.
4
Proteomimetic surface fragments distinguish targets by function.拟蛋白质表面片段通过功能区分靶标。
Chem Sci. 2020 Sep 10;11(38):10390-10398. doi: 10.1039/d0sc03525d.
5
New Advances in General Biomedical Applications of PAMAM Dendrimers.PAMAM 树状聚合物在一般生物医学应用上的新进展。
Molecules. 2018 Nov 2;23(11):2849. doi: 10.3390/molecules23112849.
6
The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer's Disease Therapeutics and Diagnostics.神经退行性疾病中的递送挑战:纳米颗粒在阿尔茨海默病治疗与诊断中的作用
Pharmaceutics. 2018 Oct 17;10(4):190. doi: 10.3390/pharmaceutics10040190.
7
Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers.折叠体-树状聚合物缀合物作为多价剂对抗淀粉样β寡聚物的毒性作用的结构优化。
Molecules. 2018 Oct 2;23(10):2523. doi: 10.3390/molecules23102523.
8
Homochirality of β-Peptides: A Significant Biomimetic Property of Unnatural Systems.β-肽的同手性:非天然体系的一种重要仿生特性。
ChemistryOpen. 2017 Jul 20;6(4):492-496. doi: 10.1002/open.201700078. eCollection 2017 Aug.
9
Small molecule probes of protein aggregation.蛋白质聚集的小分子探针
Curr Opin Chem Biol. 2017 Aug;39:90-99. doi: 10.1016/j.cbpa.2017.06.008. Epub 2017 Jun 22.
10
De Novo Modular Development of a Foldameric Protein-Protein Interaction Inhibitor for Separate Hot Spots: A Dynamic Covalent Assembly Approach.针对不同热点的折叠体蛋白-蛋白相互作用抑制剂的从头模块化开发:一种动态共价组装方法。
ChemistryOpen. 2017 Mar 13;6(2):236-241. doi: 10.1002/open.201700012. eCollection 2017 Apr.
Computational design of a β-peptide that targets transmembrane helices.
靶向跨膜螺旋的β-肽的计算设计。
J Am Chem Soc. 2011 Aug 17;133(32):12378-81. doi: 10.1021/ja204215f. Epub 2011 Jul 22.
4
Broad distribution of energetically important contacts across an extended protein interface.广泛分布的能量重要接触点横跨扩展的蛋白质界面。
J Am Chem Soc. 2011 Jul 6;133(26):10038-41. doi: 10.1021/ja203358t. Epub 2011 Jun 14.
5
Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide.淀粉样β蛋白诱导的海马突触可塑性损伤可通过减少线粒体超氧化物来挽救。
J Neurosci. 2011 Apr 13;31(15):5589-95. doi: 10.1523/JNEUROSCI.6566-10.2011.
6
Insight into amyloid structure using chemical probes.利用化学探针深入了解淀粉样蛋白结构。
Chem Biol Drug Des. 2011 Jun;77(6):399-411. doi: 10.1111/j.1747-0285.2011.01110.x. Epub 2011 Apr 26.
7
Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures.选择性识别复杂混合物中最早 Aβ 寡聚物的化学探针。
J Am Chem Soc. 2010 Dec 22;132(50):17655-7. doi: 10.1021/ja106291e. Epub 2010 Nov 24.
8
Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies.高度寡聚体特异性β-淀粉样蛋白抗体的产生和治疗效果。
J Neurosci. 2010 Aug 4;30(31):10369-79. doi: 10.1523/JNEUROSCI.5721-09.2010.
9
Rapid screening of lectins for multivalency effects with a glycodendrimer microarray.糖树状聚合物微阵列快速筛选具有多价效应的凝集素。
Chembiochem. 2010 Sep 3;11(13):1896-904. doi: 10.1002/cbic.201000340.
10
Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity.神经营养因子增强 CaMKII 活性并挽救淀粉样β肽诱导的海马突触可塑性缺陷。
J Alzheimers Dis. 2010;21(3):823-31. doi: 10.3233/JAD-2010-100264.